Concepedia

Author

Andrew B. Tobin

University of LeicesterORCID

Also Known As

A B Tobin, A. B. Tobin, A.B. Tobin, Andrew B Tobin, Andrew B. TOBIN, Andrew B. Tobin, Andrew Tobin, Andrew B. TOBIN, S. A. Dames, Tobin, Andrew

243

Publications

8.4K

Citations

52

H-Index

85

Concepts

All Affiliations

University of LeicesterUniversity of GlasgowMonash UniversityMedical Research CouncilMRC Toxicology Unit
AB

About

Andrew B. Tobin is an author at University of Leicester specializing in medicine, signal transduction, and cell signaling.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

26

35

2.3K

2

Biochemistry

13

14

1.1K

3

Natural Sciences

12

12

832

4

Health Sciences

1

1

15

5

Social Sciences

1

1

55

Andrew B. Tobin

×

94

Publications

6.1K

Citations

46

H-Index

YearCitations

Global kinomic and phospho-proteomic analyses of the human malaria parasite Plasmodium falciparum

Lev Solyakov, Jean Halbert, Mahmood M. Alam,

Nature Communications

2011

366

The experimental power of FR900359 to study Gq-regulated biological processes

Ramona Schrage, Anna-Lena Schmitz, Evelyn Gaffal,

Nature Communications

2015

357

β-Arrestin biosensors reveal a rapid, receptor-dependent activation/deactivation cycle

Susanne Nuber, Ulrike Zabel, Kristina Lorenz,

Nature

2016

208

Differential G-protein-coupled Receptor Phosphorylation Provides Evidence for a Signaling Bar Code

Adrian J. Butcher, Rudi Prihandoko, Kok Choi Kong,

Journal of Biological Chemistry

2010

202

The Pharmacology of TUG-891, a Potent and Selective Agonist of the Free Fatty Acid Receptor 4 (FFA4/GPR120), Demonstrates Both Potential Opportunity and Possible Challenges to Therapeutic Agonism

Brian D. Hudson, Bharat Shimpukade, Amanda E. Mackenzie,

Molecular Pharmacology

2013

197

Phosphoproteomics reveals malaria parasite Protein Kinase G as a signalling hub regulating egress and invasion

Mahmood M. Alam, Lev Solyakov, Andrew R. Bottrill,

Nature Communications

2015

191

DREADD Agonist 21 Is an Effective Agonist for Muscarinic-Based DREADDs<i>in Vitro</i>and<i>in Vivo</i>

Karen Thompson, Elham Khajehali, Sophie J. Bradley,

ACS Pharmacology & Translational Science

2018

185

Targeted Elimination of G Proteins and Arrestins Defines Their Specific Contributions to Both Intensity and Duration of G Protein-coupled Receptor Signaling

Elisa Alvarez‐Curto, Asuka Inoue, Laura Jenkins,

Journal of Biological Chemistry

2016

178

Identification of Orthosteric and Allosteric Site Mutations in M2 Muscarinic Acetylcholine Receptors That Contribute to Ligand-selective Signaling Bias

Karen J. Gregory, Nathan E. Hall, Andrew B. Tobin,

Journal of Biological Chemistry

2010

160

Artemisinin-resistant K13 mutations rewire Plasmodium falciparum’s intra-erythrocytic metabolic program to enhance survival

Sachel Mok, Barbara H. Stokes, Nina F. Gnädig,

Nature Communications

2021

147

Page 1